BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36067062)

  • 21. SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?
    Wijtvliet V; Wissing KM; Abramowicz D; Ledeganck KJ
    J Am Soc Nephrol; 2022 Apr; 33(4):869-870. PubMed ID: 35165123
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
    Marion O; Del Bello A; Abravanel F; Couat C; Faguer S; Esposito L; Hebral AL; Izopet J; Kamar N
    Ann Intern Med; 2021 Sep; 174(9):1336-1338. PubMed ID: 34029487
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 vaccination in solid-organ transplant recipients: generating new data as fast as possible, but taking clinical decisions as slow as necessary.
    Manuel O
    Clin Microbiol Infect; 2021 Aug; 27(8):1070-1071. PubMed ID: 34153456
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronavirus disease 2019 vaccination in transplant recipients.
    Eberhardt CS; Balletto E; Cornberg M; Mikulska M
    Curr Opin Infect Dis; 2021 Aug; 34(4):275-287. PubMed ID: 34074880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
    Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.
    Malinis M; Cohen E; Azar MM
    Am J Transplant; 2021 Aug; 21(8):2916-2918. PubMed ID: 34101990
    [No Abstract]   [Full Text] [Related]  

  • 27. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-Organ Transplant Recipient Attitudes Regarding COVID-19 and the COVID-19 Vaccines.
    Jackson RC; Halim A; Lominadze Z; Timofte I; Shetty K
    Exp Clin Transplant; 2023 Jun; 21(6):543-544. PubMed ID: 36656109
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Werbel WA; Boyarsky BJ; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL
    Ann Intern Med; 2021 Sep; 174(9):1330-1332. PubMed ID: 34125572
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.
    Boyarsky BJ; Ou MT; Greenberg RS; Teles AT; Werbel WA; Avery RK; Massie AB; Segev DL; Garonzik-Wang JM
    Transplantation; 2021 May; 105(5):e56-e57. PubMed ID: 33560728
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19 Vaccines in Pancreatic Transplant Recipients: A Single-Center Observative Study.
    Matejak-Górska M; Zielonka M; Górska H; Durlik M
    Transplant Proc; 2022 May; 54(4):925-929. PubMed ID: 35437149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral Response After Five Successive Doses of SARS-CoV-2 mRNA Vaccine in Kidney Transplant Patients.
    Cazorla JM; Villanego F; Aguilera A; Garcia T; Orellana C; Trujillo T; Gómez AM; Mazuecos A
    Transplantation; 2023 Jul; 107(7):e188-e189. PubMed ID: 37170412
    [No Abstract]   [Full Text] [Related]  

  • 33. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
    Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
    J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients.
    Huang HJ; Yi SG; Mobley CM; Saharia A; Bhimaraj A; Moore LW; Kloc M; Adrogue HE; Graviss EA; Nguyen DT; Eagar TN; Jones SL; Ankoma-Sey V; MacGillivray TE; Knight RJ; Gaber AO; Ghobrial RM
    Clin Transplant; 2022 May; 36(5):e14600. PubMed ID: 35083796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
    Sakuraba A; Luna A; Micic D
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients.
    Mazzola A; Todesco E; Drouin S; Hazan F; Marot S; Thabut D; Varnous S; Soulié C; Barrou B; Marcelin AG; Conti F
    Clin Infect Dis; 2022 Mar; 74(6):1093-1096. PubMed ID: 34166499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two Cases of Possible Exacerbation of Chronic Rejection After Anti-SARS-CoV-2 Messenger RNA Vaccination: A Case Report.
    Okamoto T; Okajima H; Ogawa E; Uebayashi EY; Yamamoto M; Kadohisa M; Yamada Y; Minamiguchi S; Haga H; Hatano E
    Transplant Proc; 2023 Apr; 55(3):530-532. PubMed ID: 36572611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients.
    Bestard O; Jouve T; Castells L; Lopez M; Muñoz M; Crespo E; Toapanta N; Esperalba J; Campos-Varela I; Pont T; Len O; Campins M; Moreso F
    Am J Transplant; 2022 Feb; 22(2):673-675. PubMed ID: 34554648
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant.
    Kamar N; Abravanel F; Marion O; Romieu-Mourez R; Couat C; Del Bello A; Izopet J
    JAMA Netw Open; 2021 Nov; 4(11):e2136030. PubMed ID: 34817587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.